Avalon Investment & Advisory’s Balchem Corp BCPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
– Sell
-30,013
Closed -$2.47M – 412
2017
Q1
$2.47M Buy
30,013
+2,908
+11% +$245K 0.08% 158
2016
Q4
$2.27M Buy
27,105
+87
+0.3% +$6.86K 0.08% 147
2016
Q3
$2.1M Buy
27,018
+188
+0.7% +$12.5K 0.08% 136
2016
Q2
$1.6M Buy
26,830
+6,546
+32% +$400K 0.06% 148
2016
Q1
$1.26M Buy
20,284
+8,077
+66% +$485K 0.05% 134
2015
Q4
$742K Buy
12,207
+2,356
+24% +$153K 0.03% 176
2015
Q3
$599K Buy
9,851
+2,691
+38% +$156K 0.03% 189
2015
Q2
$399K Buy
7,160
+1,778
+33% +$102K 0.02% 214
2015
Q1
$298K Buy
+5,382
New +$308K 0.01% 213

Other funds holding BCPC

Avalon Investment & Advisory's BCPC Position: Q2 2017 in Review

Avalon Investment & Advisory sold out of Balchem Corp (BCPC) in Q2 2017, closing a stake of 30,013 shares — an estimated $2.47M sold.

Avalon Investment & Advisory first reported a position in BCPC in Q1 2015 and held it in 9 quarters. The position peaked at $2.47M in Q1 2017. 202 funds tracked by Wall St. Rank hold BCPC as of Q2 2017.

  • Avalon Investment & Advisory reported no remaining Balchem Corp position as of Q2 2017 after selling out during the quarter.
  • Avalon Investment & Advisory sold 30,013 Balchem Corp shares in Q2 2017, an estimated $2.47M.
  • Avalon Investment & Advisory first reported a position in Balchem Corp in Q1 2015 and held it in 9 quarters.
  • Avalon Investment & Advisory's Balchem Corp position peaked at $2.47M in Q1 2017.
  • 202 funds tracked by Wall St. Rank held Balchem Corp as of Q2 2017.

Based on Avalon Investment & Advisory's 13F filing for Q2 2017, filed 14 Aug 2017.